Teiko.bio
About Teiko.bio
Teiko.bio offers a high-dimensional cytometry platform that utilizes mass cytometry and spectral flow cytometry to analyze blood-based biomarkers, enabling the detection of over 750 unique immune subsets. This technology provides clinicians with precise data on patient immune responses, facilitating informed decision-making in clinical trials.
```xml <problem> Clinical trials often require detailed analysis of patient immune responses, but traditional flow cytometry methods have limited capacity to detect the full spectrum of immune cell subsets. This limitation hinders comprehensive understanding of drug effects and patient stratification. </problem> <solution> Teiko.bio offers a high-dimensional cytometry platform that leverages mass cytometry and spectral flow cytometry to provide in-depth analysis of blood-based biomarkers. Their TokuProfile service enables detection of over 750 unique immune subsets, offering a seven-fold increase in resolution compared to conventional flow cytometry. The platform combines validated and customizable immune panels with expert gating strategy design and a CLIA-registered laboratory workflow. Data analysis is facilitated through an online web application, providing access to FCS and GatingML files, gated and statistical analyses, and unsupervised clustering. </solution> <features> - High-parameter mass cytometry and spectral flow cytometry for comprehensive immune profiling - Validated and customizable immune panels for detection of 25-40+ proteins - Analysis of approximately 300-840 immune subsets and states - CLIA-registered laboratory ensuring high-quality data - Online web application for data visualization and analysis - Access to FCS and GatingML files for custom analysis - Gated and statistical analyses, including unsupervised clustering - Streamlined workflow with simple two-step sample processing using TokuKits - Low coefficient of variation in CLIA registration packet </features> <target_audience> The primary target audience includes researchers and clinicians involved in clinical trials who require detailed immune profiling data for drug development and patient stratification. </target_audience> <revenue_model> TokuKits for whole blood collection are available starting at $100 per kit. </revenue_model> ```
What does Teiko.bio do?
Teiko.bio offers a high-dimensional cytometry platform that utilizes mass cytometry and spectral flow cytometry to analyze blood-based biomarkers, enabling the detection of over 750 unique immune subsets. This technology provides clinicians with precise data on patient immune responses, facilitating informed decision-making in clinical trials.
Where is Teiko.bio located?
Teiko.bio is based in Salt Lake City, United States.
When was Teiko.bio founded?
Teiko.bio was founded in 2020.
How much funding has Teiko.bio raised?
Teiko.bio has raised 11640000.
- Location
- Salt Lake City, United States
- Founded
- 2020
- Funding
- 11640000
- Employees
- 15 employees
- Major Investors
- Altitude Lab